Functional characteristics and gene expression profiles of primary acute myeloid leukaemia cells identify patient subgroups that differ in the susceptibility to histone deacetylase inhibitors

被引：0
|
作者：
Stapnes, C.
Ryningen, A.
Hatfield, K.
Oyan, A. M.
Eide, G. E.
Kalland, K. H.
Gjertsen, B. T.
Bruserud, O.
机构：
[1] Inst Med, Bergen, Norway
[2] Gade Inst, Bergen, Norway
[3] Clin Res Ctr, Bergen, Norway
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0309
引用
收藏
页码：112 / 112
页数：1
相关论文
共 19 条
  • [1] Functional characteristics and gene expression profiles of primary acute myeloid leukaemia cells identify patient subgroups that differ in susceptibility to histone deacetylase inhibitors
    Stapnes, Camilla
    Ryningen, Anita
    Hatfield, Kimberley
    Oyan, Anne Margrete
    Eide, Geir Egil
    Corbascio, Matthias
    Kalland, Karl-Henning
    Gjertsen, Bjorn Tore
    Bruserud, Oystein
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 31 (06) : 1529 - 1538
  • [2] Linking susceptibility to histone deactylase inhibitors and basal gene expression profiles in acute myeloid leukaemia
    Stapnes, C.
    Ryningen, A.
    Hatfield, K.
    Oyan, A.
    Kalland, K.
    Gjertsen, B.
    Bruserud, O.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 77 - 77
  • [3] Characterisation of histone deacetylase (HDAC) expression profiles in acute myeloid leukaemia: A basis for the development of targeted therapy using histone deacetylase inhibitors
    Bradbury, CA
    Khanim, FL
    Mehta, P
    Hayden, RE
    Craddock, CF
    Bunce, CM
    Turner, BM
    BLOOD, 2004, 104 (11) : 318A - 318A
  • [4] Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors
    C A Bradbury
    F L Khanim
    R Hayden
    C M Bunce
    D A White
    M T Drayson
    C Craddock
    B M Turner
    Leukemia, 2005, 19 : 1751 - 1759
  • [5] Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors
    Bradbury, C
    Khanim, F
    Hayden, R
    Bunce, CM
    White, DA
    Drayson, MT
    Craddock, C
    Turner, BM
    LEUKEMIA, 2005, 19 (10) : 1751 - 1759
  • [6] Expression of fusion proteins in acute myeloid leukemia cells increases sensitivity to histone deacetylase inhibitors
    Petruccelli, Luca A.
    Pettersson, Filippa
    Dupere-Richer, Daphne
    Rice, Kim L.
    Licht, Jonathan D.
    Miller, Wilson H., Jr.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [7] Expression of fusion proteins in acute myeloid leukemia cells increases sensitivity to histone deacetylase inhibitors
    Petruccelli, Luca A.
    Rice, Kim L.
    Pettersson, Filippa
    Nichol, Jessica N.
    Skoulikas, Sophia
    Licht, Jonathan D.
    Miller, Wilson H.
    CANCER RESEARCH, 2011, 71
  • [8] Differential effects of histone deacetylase inhibitors on interleukin-18 gene expression in myeloid cells
    Koyama, N
    Koschmieder, S
    Tyagi, S
    Nürnberger, H
    Wagner, S
    Böcker, U
    Hoelzer, D
    Ottmann, OG
    Kalina, U
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 292 (04) : 937 - 943
  • [9] A specific pattern of histone deacetylase (HDAC) expression can be identified in acute myeloid leukaemia: Relevance for targeted therapy with histone cleacetylase inhibitors
    Bradbury, CA
    Khanim, FL
    Mehta, P
    Hayden, RE
    Craddock, CF
    Bunce, CM
    Turner, BM
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 30 - 30
  • [10] Gene expression using adenoviral vectors in primary acute myeloid leukaemia cells.
    Lea, NC
    Buggins, AGS
    Hirst, WJR
    Gaken, J
    Farzaneh, F
    Mufti, GJ
    Pagliuca, A
    BLOOD, 1999, 94 (10) : 413B - 413B
12